Breaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeek
  • Home
  • Nation
  • Politics
  • Economy
  • Sports
  • Entertainment
  • International
  • Technology
  • Auto News
Reading: Danny Gaekwad’s Bid for 55% Stake in Religare Sparks Board Attention
Share
Breaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeekBreaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeek
Search
  • Home
  • Nation
  • Politics
  • Economy
  • Sports
  • Entertainment
  • International
  • Technology
  • Auto News
© 2024 All Rights Reserved | Powered by India News Week
Battle for Control: Danny Gaekwad bids to seize 55% stake in Religare, writes to REL Board
Breaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeek > Economy > Danny Gaekwad’s Bid for 55% Stake in Religare Sparks Board Attention
Economy

Danny Gaekwad’s Bid for 55% Stake in Religare Sparks Board Attention

January 27, 2025 3 Min Read
Share
SHARE

Florida-based entrepreneur Danny Gaekwad has reached out to the Board of Religare Enterprises Ltd (REL) expressing his intention to launch a rival offer to the Burman Group’s open offer, which commenced on Monday.

The communication, received by REL on Monday, comes after Gaekwad’s appeal to the SEBI Chairperson on Sunday for permission to waive certain statutory timelines under the Takeover Code. This waiver would enable him to present a competing offer to acquire a controlling 55% stake in REL.

Described as a “serious player,” Gaekwad’s letter to the REL Board reiterated the key points from his previous communication to the SEBI Chief. It also indicated his readiness to enlist a merchant banker and establish an escrow account as required by the Takeover Code, according to sources familiar with the matter. The letter underscored a specific provision (Regulation 11(1) of SAST) granting SEBI the authority to grant exemptions on statutory timelines in the interest of public shareholders.

Furthermore, Gaekwad’s letter pointed out that the Burman Group’s final letter of offer did not address the conditions set by the Reserve Bank of India in its approval, potentially posing a risk to the interests of REL’s public shareholders if the Burman Group’s open offer proceeds without a competing offer.

In an interview with a TV channel on Monday, Gaekwad described himself as a “value buyer” and expressed his belief that REL shares remain undervalued in the stock market.

Regarding Gaekwad’s proposed offer price of ₹275 per share, sources suggest that it validates the independent directors’ concerns that the Burman Group’s offer of ₹235 per share was undervalued.

While opinions among securities market experts and proxy advisors are divided on Gaekwad’s competing offer attempt, some argue that SEBI should not grant exemptions from the established statutory timelines in this case. They view this situation as a significant test for SEBI, particularly considering the need to strengthen US-India relations following Trump’s re-election and India’s desire to attract foreign direct investment from the US.

Amit Tandon, Founder and Managing Director of Institutional Investor Advisory Services (IIAS), emphasized the importance of regulators ensuring compliance with mandated timelines to uphold investor trust and process integrity. Similarly, Shriram Subramanian, Founder & MD of InGovern Research, criticized Gaekwad’s competing offer as lacking credibility and authenticity, raising concerns about the entity’s background, funding sources, and ultimate ownership.

Subramanian outlined several grounds on which SEBI could reject the Gaekwad entity’s offer, emphasizing the importance of adhering to procedural requirements and timelines to maintain the integrity of the capital markets and regulatory framework.

TAGGED:Economy NewsNews
Share This Article
Twitter Copy Link
Previous Article Investors may book profits if valuation comfort missing: Experts Valuation concerns may prompt investors to take profits: Analysts
Next Article Digital news publishers’ association joins ANI suit against OpenAI Digital News Publishers’ Association Supports ANI in Legal Action Against OpenAI
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Latest News

FILE - A parliamentary committee has urged India to diversify crude oil sources to reduce reliance on imports, which currently stand at 89%. (AP Photo/Martin Meissner, File)

‘India could face risk of crude oil import uncertainty’: Parliamentary panel urges ‘diversify sourcing’ Rewrite this headline into a unique, engaging, SEO-friendly news title. Use only English. Maximum 12 words. Output only the new title.

December 14, 2025
At least 11 killed in Australia beach shooting targeting Jewish event

Tragic Beach Shooting in Australia Claims 11 Lives at Jewish Event

December 14, 2025
More trouble for Refex Industries as SEBI imposes penalty on CMD for alleged insider trading

SEBI Slaps Penalty on Refex CMD Over Insider Trading Allegations

December 14, 2025
Capital A bets on shopfloors over unicorn hype

Capital A Prefers Tangible Shopfloors Over Overhyped Unicorn Startups

December 14, 2025
Who is R Sreelekha? Kerala’s first woman IPS officer, BJP’s top contender for mayor post in Thiruvananthapuram

R Sreelekha: Kerala’s Pioneer Woman IPS Officer & BJP’s Mayor Hopeful

December 14, 2025
Robin Uthappa picks India's optimal XI ahead of third T20I against South Africa

Robin Uthappa’s Ideal Indian XI for the Upcoming Third T20I Against South Africa

December 14, 2025

You Might Also Like

Allahabad HC refuses to quash FIR against Neha Singh Rathore for post on Modi govt politicising Pahalgam attack
Nation

Allahabad HC Upholds FIR Against Neha Singh Rathore for Modi Govt Criticism on Pahalgam Attack

3 Min Read
Crude oil futures decline as Trump asks Saudi to cut prices 
Economy

Trump urges Saudis to cut oil prices, crude futures drop

3 Min Read
Rupee slides sharply against euro, pound and yen too, besides dollar, in 2025
Economy

Rupee Declines Significantly Against Euro, Pound, Yen, and Dollar in 2025

4 Min Read
Biocon, Zentiva secure EU approval for generic diabetes and weight loss drugs 
Economy

EU approves generic diabetes and weight loss drugs from Biocon and Zentiva.

2 Min Read
Breaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeek
Breaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeek

Welcome to IndiaNewsWeek, your reliable source for all the essential news and insights from across the nation. Our mission is to provide timely and accurate news that reflects the diverse perspectives and voices within India.

  • Home
  • Nation News
  • Economy News
  • Politics News
  • Sports News
  • Technology
  • Entertainment
  • International
  • Auto News
  • Bookmarks
  • About us
  • Contact Us
  • Disclaimer
  • Privacy Policy
  • Terms of Service
  • Home
  • Nation
  • Politics
  • Economy
  • Sports
  • Entertainment
  • International
  • Technology
  • Auto News
  • About us
  • Contact Us
  • Disclaimer
  • Privacy Policy
  • Terms of Service

© 2024 All Rights Reserved | Powered by India News Week

Welcome Back!

Sign in to your account

Lost your password?